List view / Grid view

Ajay N. Jain

 

article

Obstacles and innovations of macrocyclic drug development

Macrocycles outperform traditional therapeutics on several fronts, yet they account…

16 January 2025 | By

Macrocycles outperform traditional therapeutics on several fronts, yet they account for just four percent of FDA-approved drugs. Colleagues Ann E Cleves and Ajay N Jain from Optibrium Ltd explain why we can expect to see this number increase in the coming years.